Respiratory Virus Vaccines Market: Growth Analysis By Revenue, Market Size, Share, Scenario on Latest Trends & Types, Applications to Forecast 2022-2031

“The report on Respiratory Virus Vaccines Market was recently published by SDKI, which includes the latest market trends, current and future opportunities along with the factors that are driving the growth of the market. This report further encompasses the records for the expansion of the market along with information on the investment opportunities that help the clients to take positive decisions on the parameters for gaining profitable revenues. Moreover, the report also contains identification and investigation of the market structure, in-depth qualitative analysis, restraints & challenges, growth drivers, emerging product trends & market opportunities and Porter’s five forces.

Download Sample of This Strategic Report: https://www.sdki.us/sample-request-111234

Respiratory Virus Vaccines Market: Overview

  • According to the latest research report on the global respiratory virus vaccines market for the historical year (2018), base year (2019), and the forecast period (2022-2031), increase in incidence of respiratory infections is projected to drive the global respiratory virus vaccines market in the near future
  • According to the report, the global respiratory virus vaccines market was valued at US$ 6.4 Bn in 2019. It is anticipated to expand at a CAGR of ~8% from 2022-2031
  • In terms of type, the global respiratory virus vaccines market has been classified into inactivated/killed vaccines, live-attenuated vaccines, and recombinant vaccines. Based on route of administration, the global respiratory virus vaccines market has been categorized into intramuscular, intranasal, and subcutaneous. In terms of indication, the global respiratory virus vaccines market has been classified into influenza, measles, mumps & rubella, coronavirus disease (COVID-19), and others. In terms of age group, the global respiratory virus vaccines market has been divided into pediatric and adults. In terms of end user, the global respiratory virus vaccines market has been classified into physician offices, hospitals, clinics, pharmacies/stores, and others.

Increase in Burden of Respiratory Illnesses to Drive Respiratory Virus Vaccines Market

  • Rise in prevalence of respiratory illnesses and demand for newer vaccines for the prevention of respiratory infections, and large number of pharmaceutical companies participating in the race to develop vaccine for the novel coronavirus are major factors projected to boost the respiratory virus vaccines market during the forecast period
  • As per the World Health Organization, 290,000 to 650,000 people die globally, every year, due to flu-related illnesses

Government Initiatives to Expand Vaccination Coverage to Propel Respiratory Virus Vaccines Market

  • In April 2017, the Government of Canada announced its decision to invest C$ 1.7 Mn in the Immunization Partnership Fund in order to fund three new projects aimed at expanding the vaccination coverage in Canada
  • In February 2017, the Government of India launched the ‘Pan-India campaign for Measles-Rubella Vaccination’ to help protect children from major childhood diseases viz. rubella and measles. This nationwide vaccination campaign aims to administer measles-rubella vaccine (MR-VAC) to children aged between nine months and 15 years of age.

Respiratory Virus Vaccines Market: Competition Landscape

  • This report profiles major players operating in the global respiratory virus vaccines market based on attributes such as company overview, financial overview, product portfolio, major brands, business strategies, and recent developments
  • The global respiratory virus vaccines market is marked by the presence of a few large players operating in the international market and some small players in regional markets. The top players hold a major share of the global respiratory virus vaccines market.
  • Developing a vaccine for the novel coronavirus has become a need of an hour. Amid the coronavirus crisis, several pharmaceutical companies are developing vaccine for COVID-19, with promising drug candidate in phase I and phase II in clinical trials.
  • Prominent players operating in the global respiratory virus vaccines market include –
    • CSL Limited
    • Sanofi
    • AstraZeneca
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Sinovac Biotech Ltd.
  • In April 2020, Sanofi entered into a collaboration with GlaxoSmithKline plc to accelerate the development of its vaccine against the novel coronavirus, SARS-CoV-2
  • In April 2020, AstraZeneca partnered with University of Oxford to develop a vaccine for COVID-19. The company has planned to submit the vaccine for fast track regulatory approval. It also plans to launch the vaccine in the U.K. and globally by the end for the year, if it gains regulatory approval.
  • In April 2020, Serum Institute of India Pvt. Ltd. entered into a partnership with University of Oxford to accelerate the development of a vaccine for COVID-19, developed by Oxford
  • The report on the global respiratory virus vaccines market discusses individual strategies, followed by company profiles of manufacturers of respiratory virus vaccines drugs and therapies. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global respiratory virus vaccines market.

Respiratory Virus Vaccines Market – Scope of the Report

The report on the global respiratory virus vaccines market studies the past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global respiratory virus vaccines market for period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global respiratory virus vaccines market for the same period.

The report has been prepared after extensive research. Primary research involves bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global respiratory virus vaccines market.

Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global respiratory virus vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global respiratory virus vaccines market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global respiratory virus vaccines market. The next section of the report highlights the USPs, which include pipeline analysis, disease prevalence & incidence rate globally with key countries, key industry events (mergers, acquisitions, collaborations, approvals, etc.) and COVID-19 pandemic impact on industry (value chain and short-/mid-/ long-term impact).

The report delves into the competitive landscape of the global respiratory virus vaccines market. Key players operating in the global respiratory virus vaccines market have been identified and each one of them has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global respiratory virus vaccines market profiled in this report.

Key Questions Answered in Respiratory Virus Vaccines Market Report

  • What are the major drivers, restraints, and opportunities in the global respiratory virus vaccines market?
  • What is the revenue share projection of key segments of the global respiratory virus vaccines market during the forecast period?
  • Which segment is likely to lead the global respiratory virus vaccines market in terms of revenue between 2020 and 2030?
  • How mergers & acquisitions among players are widening the scope of the global respiratory virus vaccines market?
  • What is the market position of different companies operating in the global respiratory virus vaccines market?

Respiratory Virus Vaccines Market – Research Objectives and Research Approach

The comprehensive report on the global respiratory virus vaccines market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global respiratory virus vaccines market. It is followed by market introduction, market dynamics, and an overview of the global respiratory virus vaccines market, which includes the analysis of market drivers, restraints, and trends pertaining to the global respiratory virus vaccines market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global respiratory virus vaccines market. The next section of the global respiratory virus vaccines report highlights the USPs, which include pipeline analysis, disease prevalence & incidence rate globally with key countries, key industry events (mergers, acquisitions, collaborations, approvals, etc.) and COVID-19 pandemic impact on industry (value chain and short-/mid-/long-term impact).

For more information about this report visit: Respiratory Virus Vaccines Market

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report segments the global respiratory virus vaccines market in terms of type, route of administration, indication, age group, end user, and region. Key segments under each criterion have been studied at length and the market share for each segment by the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global respiratory virus vaccines market.

Related Posts:

Process Automation and Instrumentation Market
Steel Wire Market
Steel Wire Market
Precious Metals E-Waste Recovery Market

Leave a Reply

Your email address will not be published. Required fields are marked *